Attis Lab is a pioneering company that develops a personalized treatment and drug screening platform for chronic disease and cancer patients, based on 3D organoid culturing technology. Their technology includes the development of patient-specific cell therapies for chronic disease treatment, a personalized anti-cancer treatment platform, and the development of patient-specific replicated organs.

Attis Lab aims to establish a complete patient-specific regenerative medicine platform, from diagnosis to treatment, focusing on the development of therapeutics for patient-specific disease treatment.

Attis Lab was established in 2019 and has become a leading company in the field of 3D organoids. We have also made significant strides in the field of hair loss and skin improvement, with these areas being potential early commercialization opportunities.